OMNI RAIL PRODUCTS INC
NT 10-Q, 1999-09-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: CAMERON ASHLEY BUILDING PRODUCTS INC, 10-Q, 1999-09-14
Next: APPLIED DIGITAL ACCESS INC, SC 14D9, 1999-09-14






                     U.S. SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One):
[ ] Form 10-K   [ ] Form 20-F  [ ] Form 11-K  [x] Form 10-Q  [ ] Form N-SAR

For Period Ended:  July 31, 1999

[ ]  Transition Report on Form 10-KSB
[ ]  Transition Report on Form 20-F
[ ]  Transition Report on Form 11-K
[ ]  Transition Report on Form 10-QSB
[ ]  Transition Report on Form N-SAR

For the Transition Period Ended:

Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:

Not applicable.

- --------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION
- --------------------------------------------------------------------------------

Full Name of Registrant:            OMNI Rail Products, Inc.

Former Name if Applicable:          Creative Medical Development, Inc.

Address of Principal Executive
Office (Street and Number):         975 SE Sandy Boulevard

City, State and Zip Code:           Portland, Oregon  97214

- --------------------------------------------------------------------------------

PART II - RULES 12b-25(b) and (c)
- --------------------------------------------------------------------------------

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

     (a)  The reasons  described in  reasonable  detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

     (b)  The subject annual report,  semi-annual  report,  transition report on
          Form 10-KSB, Form 20-F, 11-K or Form N-SAR, or portion thereof will be
          filed on or before the fifteenth calendar day following the prescribed
          due date; or the subject quarterly report or transition report on Form
          10-QSB,  or  portion  thereof  will be filed on or  before  the  fifth
[X]       calendar day following the prescribed due date; and

     (c)  The accountant's statement or other exhibit required by Rule 12b-25(c)
          has been attached if applicable.

- --------------------------------------------------------------------------------

<PAGE>


PART III - NARRATIVE
- --------------------------------------------------------------------------------

State below in reasonable  detail the reasons why the Form 10-KSB,  20-F,  11-K,
10-QSB or N-SAR or the transition  report or portion  thereof could not be filed
within the prescribed period.

Registrant is not yet able to close its quarterly records.

- --------------------------------------------------------------------------------

PART IV - OTHER INFORMATION
- --------------------------------------------------------------------------------

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification: M. Charles Van Rossen, (503) 230-8034

(2)  Have all other period  reports  required  under  section 13 or 15(d) of the
     Securities Exchange Act of 1934 or section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such report(s) been filed? If the answer is
     no, identify report(s). [X] Yes [ ] No

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  of  portion
     thereof?  [ ] Yes [X] No

     If so: attach an explanation of the anticipated  change,  both  narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

- --------------------------------------------------------------------------------


                            OMNI Rail Products, Inc.
                        --------------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.



Date: September 13, 1999                 By: /s/ M. Charles Van Rossen
- ------------------------                 ---------------------------------------
                                         M. Charles Van Rossen, CFO


INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

Intentional  misstatements  or omissions  of fact  constitute  Federal  Criminal
Violations (See 18 U.S.C. 1001)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission